TRAZIMERA POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 440MG/ VIAL
Product details
Registration number: SIN16038P
Classification: Prescription Only
Active ingredients: Trastuzumab
Strength: 440 mg/vial
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route: INTRAVENOUS
Registrant: PFIZER PRIVATE LIMITED
ATC code: L01XC03
HSA approval date: 11 November 2020
Manufacturer(s): Pfizer Manufacturing Belgium NV
Manufacturing country/countries: BELGIUM
What are the HSA registration number and classification for TRAZIMERA POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 440MG/ VIAL?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN16038P
Classification: Prescription Only
What active ingredients and strength are recorded for TRAZIMERA POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 440MG/ VIAL?
According to the HSA dataset updated 7 August 2026:
Active ingredients: Trastuzumab
Strength: 440 mg/vial
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for TRAZIMERA POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 440MG/ VIAL?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route: INTRAVENOUS
Who is the recorded registrant for TRAZIMERA POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 440MG/ VIAL?
According to the HSA dataset updated 7 August 2026:
Registrant: PFIZER PRIVATE LIMITED
Which manufacturers and countries are listed for TRAZIMERA POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 440MG/ VIAL?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s): Pfizer Manufacturing Belgium NV
Manufacturing country/countries: BELGIUM
Where can I look up TRAZIMERA POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 440MG/ VIAL in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN16038P or the exact product name TRAZIMERA POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 440MG/ VIAL. The general register link does not preselect this product.
What are the source dates for this TRAZIMERA POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 440MG/ VIAL record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this TRAZIMERA POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION 440MG/ VIAL record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN16038P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)